The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

INTRODUCTION: ALK gene rearrangement is observed in a small subset (3–7%) of non-small cell lung cancer (NSCLC) patients. The efficacy of crizotinib was shown in lung cancer patients harbouring ALK rearrangement. Nowadays, the analysis of ALK gene rearrangement is added to molecular examination of p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wojas-Krawczyk, Kamila, Krawczyk, Paweł Adam, Ramlau, Rodryg Adam, Szumiło, Justyna, Kozielski, Jerzy, Kalinka-Warzocha, Ewa, Bryl, Maciej, Knopik-Dąbrowicz, Alina, Spychalski, Łukasz, Szczęsna, Aleksandra, Rydzik, Ewelina, Milanowski, Janusz
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2013
Teme:
Original Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934043/
https://ncbi.nlm.nih.gov/pubmed/24592134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2013.38758
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items